Tremelimumab and durvalumab combination for the non-operative management (Nom) of microsatellite instability (msi)-high resectable gastric or gastroesophageal junction cancer: The multicentre, single-arm, multi-cohort, phase ii infinity study

MLA

Giovanni Gerardo Cardellino, et al. Tremelimumab and Durvalumab Combination for the Non-Operative Management (Nom) of Microsatellite Instability (Msi)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase Ii Infinity Study. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a7d42eb7021ab2e3d221d6c6e6d9cce7&authtype=sso&custid=ns315887.

APA

Giovanni Gerardo Cardellino, Federica Palermo, Roberto Murialdo, Chiara Cremolini, Lorenzo Antonuzzo, Massimo Di Maio, Francesca Pucci, Giovanni Luca Frassineti, Sara Lonardi, Emiliano Tamburini, Giuseppe Aprile, Massimo Aglietta, Lorenzo Fornaro, Margherita Ratti, Stefano Tamberi, Francesco Iachetta, Carlo Sposito, Antonia Strippoli, Alessandra Raimondi, … Giovanni de Manzoni. (2021). Tremelimumab and durvalumab combination for the non-operative management (Nom) of microsatellite instability (msi)-high resectable gastric or gastroesophageal junction cancer: The multicentre, single-arm, multi-cohort, phase ii infinity study.

Chicago

Giovanni Gerardo Cardellino, Federica Palermo, Roberto Murialdo, Chiara Cremolini, Lorenzo Antonuzzo, Massimo Di Maio, Francesca Pucci, et al. 2021. “Tremelimumab and Durvalumab Combination for the Non-Operative Management (Nom) of Microsatellite Instability (Msi)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase Ii Infinity Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a7d42eb7021ab2e3d221d6c6e6d9cce7&authtype=sso&custid=ns315887.